BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Nine Anticipated FDA Approvals for January 2026 Guideline Central RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion GHK Cu LifeStyle Peptides